BioMonde (Biotechnology) Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

BioMonde (Biotechnology) General Information

Description

Manufacturer of larval therapy products used to treat wounds like diabetic ulcers and orthopedic wounds. The company produces and distributes fly maggots for wound treatment at clinics, thereby enabling the clients to heal quickly.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Units 2-4 Dunraven Business Park
  • Coychurch Road
  • Bridgend CF31 3BG
  • Wales, United Kingdom
Primary Industry
Biotechnology
Other Industries
Distributors (Healthcare)
Acquirer
Biomonde
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Units 2-4 Dunraven Business Park
  • Coychurch Road
  • Bridgend CF31 3BG
  • Wales, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMonde (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Apr-2010 Completed Generating Revenue
2. Later Stage VC 01-Jan-2005 Completed Generating Revenue
1. Later Stage VC Completed Startup
To view BioMonde (Biotechnology)’s complete valuation and funding history, request access »

BioMonde (Biotechnology) Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Development Bank of Wales Venture Capital Minority
New Hill Management Venture Capital Minority
Oxford Capital Partners Venture Capital Minority
To view BioMonde (Biotechnology)’s complete investors history, request access »

Ready to get started?

Request a free trial

BioMonde (Biotechnology) FAQs

  • When was BioMonde (Biotechnology) founded?

    BioMonde (Biotechnology) was founded in 1996.

  • Where is BioMonde (Biotechnology) headquartered?

    BioMonde (Biotechnology) is headquartered in Bridgend, United Kingdom.

  • What industry is BioMonde (Biotechnology) in?

    BioMonde (Biotechnology)’s primary industry is Biotechnology.

  • Is BioMonde (Biotechnology) a private or public company?

    BioMonde (Biotechnology) is a Private company.

  • What is BioMonde (Biotechnology)’s current revenue?

    The current revenue for BioMonde (Biotechnology) is .

  • How much funding has BioMonde (Biotechnology) raised over time?

    BioMonde (Biotechnology) has raised $5.98M.

  • Who are BioMonde (Biotechnology)’s investors?

    Development Bank of Wales, New Hill Management, and Oxford Capital Partners have invested in BioMonde (Biotechnology).

  • When was BioMonde (Biotechnology) acquired?

    BioMonde (Biotechnology) was acquired on 01-Apr-2010.

  • Who acquired BioMonde (Biotechnology)?

    BioMonde (Biotechnology) was acquired by Biomonde.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »